r.a

So Í'd like to focus on 'The Product' and give my honest thoughts. Feedback welcome. Haters also welcome.

When I bought in around Jan 2010 this drug was all about Rheumatoid Arthritis, or 'RA'as we all now refer to it. There was a small sample trial with excellent results (along with excellent placebo results), a big Phase II trial underway that was the focus of many years worth of focus, $$, and announcements, and an ongoing dialogue with shareholders that commercialisation, most specifically for R.A, was the number 1 goal. Wealth for all was imminent.

The results were released, and we all - maybe hanging on to one of the more unrealisitic human states of being - HOPE - held on to the notion that the trial was not dead in the water and somehow the words used to announce it to the market were at fault, - not the results. Right?
This continued to be the theme of the SAG - from their view the drug was fine and it was 'simply' a dosing issue.

So the recent Shareholder update had two big fat Elephants in the Room:
1) A 180 Degree turnaround on official position re R.A trials. From a position of it being a dosing issue, quoted in a number of letters I received in my mailbox, to the shareholder update (released same day Cameron sold down half her shares), stating :
"to suggest that a higher does may be equally well tolerated and show good efficacy is a scientifically unsubstantiatied speculation".

COMPLETE TURONAROUND IN POSITION, and more so, this position was a part of the mandate on which they lobbied for office.

2) R.A has all but dissappeared from recent announcements re the future.

I personally DO NOT WANT TO HEAR ABOUT LUPUS. It was always a backup. WHAT HAPPENDED TO THE MAIN GAME?

If R.A is dead in the water, call it out now. Forget the BS and hope creation. The SP is already gone to cash. The truth won't hurt it much more.

It's time for the truth. What did you find in the files, SAG?